Abiopharma

News list

Director O'Brien David J. 🟢 acquired 1.7K shares (1 derivative) of Elauwit Connection, Inc. (ELWT) Transaction Date: Apr 02, 2026 | Filing ID: 000129

Full text

News bot April 6, 2026, 8:36 p.m.
🔍 O'Brien David J. (Director)

Company: Elauwit Connection, Inc. (ELWT)

Report Date: 2026-04-02
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 2
- Total shares acquired: 1,693
- Total shares held: 275,170
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By Cara Capital, LLC | shares_owned_after: 213,001.00 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By Cara Capital VC 1, LLC | shares_owned_after: 62,169.00 | Footnotes: F2
- Acquired 1,693 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,693.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3
Footnotes:
- F1: David O'Brien is the managing director of Cara Capital, LLC.
- F2: David O'Brien is the managing director of Cara Capital VC 1, LLC.
- F3: These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the Elauwit Connection, Inc. 2025 Stock Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest on the first anniversary of the date of grant.